#Uzbekistan #Tashkent #Sandstone Medical #Easydrip Plus #SteriLance Medical

Sandstone Medical's New Easydrip™ Plus Pen Needles Debuting in Uzbekistan

TASHKENT, Uzbekistan – September 2, 2025 – Sandstone Medical, a sub-brand of SteriLance Medical, has announced the exciting launch of its Easydrip™ Plus pen needles in Uzbekistan. This new product aims to bridge the gap between high-end offerings and lower-quality alternatives in the market, focusing on enhancing the daily injection experience for diabetes patients.

The launch addresses a significant need within a market that has long been characterized by a stark divide between premium international brands and low-cost products that often lack consistency and reliability. The Easydrip™ Plus pen needles are designed with a large-platform hub that ensures a steady grip and better control during injections, providing a more comfortable experience.

A key feature of the Easydrip™ Plus is its thin-wall, polished, multi-facet needle, which allows for smooth and gentle insertion while ensuring a reliable flow. This design element is particularly important for diabetic patients, as many may experience anxiety related to frequent self-injections. By improving the injection process, Sandstone aims to increase adherence rates.

The Easydrip™ Plus pen needles come in various gauges and lengths, compatible with widely used insulin pens, and are single-use and sterilized for optimal safety. Sandstone Medical places a strong emphasis on real-world usability, providing clear instructions for use and pharmacy-friendly packaging to simplify the process for patients and healthcare providers alike.

These pen needles are available through major hospital and pharmacy networks nationwide, with plans for expansion into additional cities as demand grows. Sandstone is also committed to providing educational materials for clinicians and people living with diabetes, ensuring that patients are well-informed about their options and usage.

Initial feedback from users has been extremely positive, with many highlighting the comfortable handling and reliable performance of the Easydrip™ Plus pen needles. As part of its outreach strategy, Sandstone plans to further boost access to the product through e-commerce channels and by leveraging influencer-led education to reach more patients.

A representative from Sandstone Medical emphasized the brand's mission: “Our goal is to balance a premium experience with accessibility, ensuring that patients in Uzbekistan can achieve safer and more comfortable daily injections.”

The Easydrip™ Plus pen needles are produced under strict ISO 13485 quality management standards and hold CE certification, which confirms their adherence to international safety and performance standards. This guarantees that patients will have access to a high-quality product that meets their medical needs.

About Sandstone Medical and SteriLance Medical

Sandstone Medical is recognized for developing patient-centric solutions aimed at enhancing diabetes self-care. Operating under the SteriLance Medical umbrella, which was founded in 1993, the company boasts a portfolio of over 200 global patents and products distributed to more than 50 countries worldwide. This extensive reach reflects Sandstone’s commitment to providing effective and innovative solutions in the healthcare industry.

To find out more information about their products, visit Sandstone Medical and SteriLance Medical.